Vorderstrasse Allison A, Ginsburg Geoffrey S, Kraus William E, Maldonado Maj Carlos J, Wolever Ruth Q
Duke University School of Nursing, United States.
Institute for Genome Sciences & Policy, United States.
Glob Adv Health Med. 2013 May;2(3):26-38. doi: 10.7453/gahmj.2013.035.
Type 2 diabetes (T2D) and coronary heart disease (CHD) are prevalent chronic diseases from which military personnel are not exempt. While many genetic markers for these diseases have been identified, the clinical utility of genetic risk testing for multifactorial diseases such as these has not been established. The need for a behavioral intervention such as health coaching following a risk counseling intervention for T2D or CHD also has not been explored. Here we present the rationale, design, and protocol for evaluating the clinical utility of genetic risk testing and health coaching for active duty US Air Force (AF) retirees and beneficiaries.
Determine the direct and interactive effects of health coaching and providing genetic risk information when added to standard risk counseling for CHD and T2D on health behaviors and clinical risk markers.
Four-group (2 X 2 factorial) randomized controlled trial.
Two AF primary care clinical settings on the west coast of the United States.
Adult AF primary care patients.
All participants will have a risk counseling visit with a clinic provider to discuss personal risk factors for T2D and CHD. Half of the participants (two groups) will also learn of their genetic risk testing results for T2D and CHD in this risk counseling session. Participants randomized to the two groups receiving health coaching will then receive telephonic health coaching over 6 months.
Behavioral measures (self-reported dietary intake, physical activity, smoking cessation, medication adherence); clinical outcomes (AF composite fitness scores, weight, waist circumference, blood pressure, fasting glucose, lipids, T2D/CHD risk scores) and psychosocial measures (self-efficacy, worry, perceived risk) will be collected at baseline and 6 weeks, and 3, 6, and 12 months.
This study tests novel strategies deployed within existing AF primary care to increase adherence to evidence-based diet, physical activity, smoking cessation, and medication recommendations for CHD and T2D risk reduction through methods of patient engagement and self-management support.
2型糖尿病(T2D)和冠心病(CHD)是常见的慢性病,军事人员也不能幸免。虽然已经确定了这些疾病的许多遗传标记,但对于此类多因素疾病的遗传风险检测的临床效用尚未确立。对于T2D或CHD进行风险咨询干预后,是否需要诸如健康指导之类的行为干预也尚未得到探讨。在此,我们介绍了评估美国空军(AF)现役退休人员及其受益人的遗传风险检测和健康指导的临床效用的基本原理、设计和方案。
确定在冠心病和2型糖尿病的标准风险咨询中加入健康指导和提供遗传风险信息对健康行为和临床风险标志物的直接和交互作用。
四组(2×2析因)随机对照试验。
美国西海岸的两个空军初级保健临床机构。
成年空军初级保健患者。
所有参与者将与诊所提供者进行一次风险咨询就诊,讨论2型糖尿病和冠心病的个人风险因素。一半参与者(两组)还将在此次风险咨询过程中了解其2型糖尿病和冠心病的遗传风险检测结果。随机分配到接受健康指导的两组参与者随后将在6个月内接受电话健康指导。
行为指标(自我报告的饮食摄入、身体活动、戒烟、药物依从性);临床结局(空军综合健康评分、体重、腰围、血压、空腹血糖、血脂、2型糖尿病/冠心病风险评分)以及心理社会指标(自我效能感、担忧、感知风险)将在基线、6周、3个月、6个月和12个月时收集。
本研究测试了在现有空军初级保健中采用的新策略,通过患者参与和自我管理支持的方法,提高对基于证据的饮食、身体活动、戒烟以及降低冠心病和2型糖尿病风险的药物推荐的依从性。